Immunai company information, Employees & Contact Information

AstraZeneca pens fresh IBD collab with long-term AI partner Immunai worth $85M Fierce Biotech

Immunai Announces Agreement to advance an Inflammatory Bowel Disease Target with AstraZeneca WebWire

Immunai strikes $85M deal with AstraZeneca to develop new IBD drug target CTech

Immunai & Parker Institute to Build Largest Single-Cell Immune Profiling Patient Database - HIT Consultant

Teva and Immunai partner to improve clinical decision making PharmaTimes

Israeli biotech startup Immunai raises $215m for drug discovery platform The Times of Israel

Immunai and Baylor College of Medicine Provide Updated Interim Phase 1 Results for anti-GD2 CAR NKT-Cell Therapy in Relapsed/Refractory Neuroblastoma Business Wire

Immunai announces collaboration with AstraZeneca for advanced clinical trial optimization WebWire

Improving drug development with a vast map of the immune system MIT News

AstraZeneca expands Immunai collaboration to tackle inflammatory bowel disease FirstWord Pharma

AstraZeneca in AI collaboration with Immunai to inform cancer drug trials Reuters

Immunai and AstraZeneca take collaboration further with IBD deal The Pharma Letter

How AI advances will shape the drugmaker of the future PharmaVoice

Immunai and Teva launch multi-tear AI collaboration for smarter drug development CTech

Beyond the gut Science | AAAS

Inside Immunai: Can artificial intelligence map our immune system? The Jerusalem Post

Immunai Enters Collaboration with Teva focused on Immunology & Immuno-Oncology Contract Pharma

AstraZeneca extends AI immuno-oncology R&D pact with Immunai Fierce Biotech

Immunai Raises $215 Million to Accelerate Development of Its Immune-First Drug Actuary Platform WebWire

Immunai Launches With $20M Seed Funding And Plan To Map The Immune System Crunchbase News

Immunai Scores $215 Million to Accelerate Mapping of the Immune System BioSpace

Immunai to Advance Inflammatory Bowel Disease Target with AstraZeneca Contract Pharma

Biotech Startup Immunai Raises $60M To Fuel Growth Of Drug Discovery Platform NoCamels

Immunai secures $215M for immune system map, fuel more acquisitions Fierce Biotech

From Atlas to Actuary: Immunai Expands Immune Mapping with $215M in Series B Genetic Engineering and Biotechnology News

Immunai acquires single-cell data developer Dropprint Genomics to build out its immune system atlas Fierce Biotech

Immunai, AstraZeneca expand partnership to target inflammatory bowel disease Ynetnews

Biotech Immunai, pharma Teva join to develop cancer treatments The Jerusalem Post

AstraZeneca invests $18 million in Immunai’s AI technology Digital Watch Observatory

Biotech Immunai Launched Out of Stealth With $20 Million in Funding businessinsider.com

Former Pfizer chief scientist joins Immunai’s board of directors The Jerusalem Post

Immunai and AstraZeneca's $18 Million AI Collaboration to Transform Cancer Drug Development geneonline.com

Mikael Dolsten joins Israel biotech company The Jerusalem Post

Biotech startup Immunai earns unicorn status with $215 million Series B CTech

This Biotech Company Combines Single Cell Genomics with Machine Learning (ML) Algorithms To Enable High Resolution Profiling of the Immune System MarkTechPost

Israeli AI startup forges $18m partnership with AstraZeneca for cancer drug trials The Times of Israel

Immunai to collaborate with AstraZeneca on oncology clinical trials The Jerusalem Post

Immunai announces a $215M Series B as its ‘immune cell atlas’ matures TechCrunch

AstraZeneca Joins Forces With Immunai In $18 Million AI Deal Finimize

Immunai Announces $20 Million Seed Round to Fund Immune System Mapping CTech

Immunai raises $60M as it expands from improving immune therapies to discovering new ones, too TechCrunch

The Hottest Startups in Tel Aviv WIRED

Biotech firm Immunai takes lab, office space at Alexandria Center for Life Science The Business Journals

Israel's Immunai expands strategic tie with AstraZeneca Globes - Israel Business News

Biotech Startup Immunai Moving HQ to Alexandria Center for Life Science Commercial Observer

Drug discovery and analysis co Immunai raises $215m Globes - Israel Business News